THE CHROMOSOME | Clinical Content Series
Melatonin Disruption
Back to Case Studies ArchiveCase Study
She was 39 years old and had not slept properly in four years. Not dramatically, not in the way of someone who lies awake all night or cannot sleep at all, but in the more insidious way of a person who spends eight hours in bed and wakes feeling as though she has slept for four. She fell asleep without significant difficulty. She simply never reached the depth of sleep that makes sleep restorative. She described her nights as a long, shallow drift, present enough to be technically asleep, absent enough to never feel the restoration that sleep is supposed to provide.
She had gained 22 kilograms across those four years. She craved sugar and carbohydrates in a way that felt physical rather than psychological, a biological demand that arrived every evening around nine or ten o clock and that she had stopped trying to resist because resistance produced a discomfort that felt more like genuine physiological need than ordinary appetite. She was hungry in the morning despite having eaten adequately the night before. Her weight had settled predominantly around her abdomen and was accumulating at a rate that no dietary modification had meaningfully slowed.
She had been told her sleep problem was stress. She had been prescribed a benzodiazepine by one physician and a sedating antihistamine by another. Both had produced a heavier, more sedated version of the shallow sleep she was already experiencing without producing the deep, restorative quality whose absence was driving her metabolic deterioration. She had been told her weight gain was a consequence of her eating habits, specifically, the evening carbohydrate consumption that she had tried to explain was a craving she could not control rather than a preference she had chosen.
Nobody had connected the sleep to the weight. Nobody had considered that the craving, the weight gain, the morning hunger, and the unrestorative sleep might share a single hormonal origin, and that the hormone at that origin was one that Pakistani medicine almost never measures and almost never considers in the context of obesity.
Melatonin. The hormone of darkness, of circadian timing, of sleep initiation and depth, of metabolic regulation, of insulin sensitisation, and of the precise biological orchestration of the body's overnight repair, restoration, and hormonal reset, the process on which every other hormonal system depends for its daily recalibration and without which every other hormonal intervention is working against a current that never reverses.
Her melatonin profile, measured through salivary sampling across the evening and overnight hours, showed a pattern that was simultaneously diagnostic and entirely unsurprising given her history. Her melatonin onset was delayed by more than three hours relative to her sleep timing, her pineal gland was not beginning significant melatonin production until after midnight, when she had been attempting sleep since ten thirty. The peak level she achieved was substantially lower than the level required to drive the deep slow wave sleep in which growth hormone is released, cortisol is suppressed, cellular repair occurs, leptin is produced, ghrelin is inhibited, and insulin sensitivity is reset for the following day. And her morning melatonin clearance was sluggish, persisting into the early morning hours and contributing to the groggy, unrefreshed waking that she had been experiencing daily.
This was melatonin disruption, a disorder of circadian melatonin rhythm that is present in a substantial and systematically underestimated proportion of Pakistani patients presenting with unexplained weight gain, poor sleep quality, evening carbohydrate craving, and metabolic deterioration that does not respond to dietary modification. It is underestimated because melatonin is understood in Pakistani medicine, to the extent that it is understood at all, as a sleep aid, a supplement that can be taken to help with jet lag or occasional insomnia, rather than as a critical metabolic hormone whose disruption drives insulin resistance, visceral fat accumulation, appetite dysregulation, and the suppression of the overnight hormonal restoration processes that every other endocrine intervention depends upon.
The drivers of her melatonin disruption were precisely identifiable. She was using her mobile phone in bed until eleven or eleven thirty, the blue light spectrum of the screen suppressing pineal melatonin production at precisely the time when melatonin onset should have been occurring. Her bedroom was not fully dark, a streetlight illuminated her curtains sufficiently to provide the low level light exposure that suppresses melatonin synthesis even when the eyes are closed. She was eating her largest meal of the day at nine or ten in the evening, activating the peripheral circadian clocks of the digestive system at the time when the central circadian clock should have been signalling rest and metabolic deceleration, creating a circadian conflict that disrupted melatonin timing and amplitude. And the visceral fat that had accumulated across four years of disrupted sleep was generating the inflammatory cytokines that directly impair pineal melatonin synthesis, adding a biological driver to the environmental ones.
The FTO gene's relationship with melatonin disruption in Pakistani patients is among the most recently characterised and most clinically significant aspects of the FTO associated metabolic profile. Research has identified FTO gene variants that directly influence circadian rhythm regulation, altering the sensitivity of circadian timing mechanisms to light exposure and meal timing signals in ways that predispose carriers to melatonin disruption, delayed sleep phase, and the metabolic consequences of circadian misalignment. Pakistani patients with the FTO associated metabolic profile may be constitutionally predisposed to melatonin disruption in ways that are amplified, rather than created, by the environmental and lifestyle factors of Pakistani urban life. The late evening culture of Pakistani social life, the widespread use of screens until late at night, the tradition of heavy evening meals, and the poorly darkened sleeping environments of Pakistani urban homes create a melatonin disruption environment that operates powerfully on a population that may carry a genetic predisposition to circadian vulnerability.
We did not prescribe a sedative. We treated the melatonin disruption at its origin, addressing every environmental driver with clinical precision while simultaneously treating the metabolic consequences of four years of disrupted overnight restoration. We eliminated screen exposure after nine in the evening. We achieved complete bedroom darkness. We shifted her meal timing to earlier in the evening. We used precisely timed low dose melatonin to begin resetting her circadian onset, not as a long term replacement but as a biological anchor while her endogenous rhythm was being recalibrated. We reduced her visceral fat, removing the inflammatory pineal suppression that had been compounding the environmental disruption. We treated her insulin resistance, which melatonin disruption had driven and which was itself further disrupting her sleep by producing the nocturnal cortisol and glucose fluctuations that prevented deep sleep maintenance.
Nine months later she described her sleep as completely transformed. She was falling asleep within twenty minutes of lying down and sleeping through without waking. She was waking spontaneously five to ten minutes before her alarm, the biological signature of a circadian rhythm that has reset to alignment with the waking time rather than one still fighting toward sleep when the alarm demands wakefulness. Her evening carbohydrate craving had disappeared entirely, which was the finding she found most remarkable, because she had been convinced it was a psychological weakness rather than a biological signal whose origin was the melatonin and insulin dysregulation of disrupted circadian timing. She had lost 18 kilograms.
She had not had an eating problem. She had had a timing problem, a circadian hormonal disruption whose metabolic consequences had been accumulating for four years while she was being told to try harder at both sleeping and eating.
FAQs
Melatonin is the pineal gland hormone that signals darkness and governs circadian timing, orchestrating the body's biological transition from the active metabolic state of wakefulness to the restorative, repair oriented state of deep sleep. Beyond its circadian role, melatonin is a critical metabolic hormone, it sensitises insulin receptors in peripheral tissues, suppresses the cortisol that drives overnight hepatic glucose production, stimulates growth hormone release, promotes leptin production that signals satiety, and inhibits ghrelin that drives hunger. When melatonin is disrupted, delayed in onset, reduced in amplitude, or absent in its circadian precision, every one of these overnight metabolic restoration processes is simultaneously impaired. Pakistani patients with melatonin disruption gain weight not because they eat more in any simple caloric sense, but because the overnight hormonal environment that should be resetting their metabolic systems for the following day is chronically and progressively failing to do so.
Pakistani culture creates a circadian environment that is systematically hostile to melatonin production and circadian alignment. Heavy evening meals eaten at nine or ten at night activate peripheral digestive circadian clocks at the time when the central circadian clock should be signalling metabolic deceleration and melatonin onset, creating a circadian conflict that disrupts melatonin timing independently of light exposure. Widespread screen use until late in the evening suppresses pineal melatonin production through blue light exposure at precisely the time when melatonin should be rising. Poorly darkened sleeping environments provide the low level light exposure that suppresses melatonin synthesis even when the eyes are closed. And the FTO associated circadian sensitivity that a significant proportion of Pakistani patients carry makes the circadian disruption produced by these environmental factors more severe and more metabolically damaging than the same exposures would produce in patients without this genetic predisposition.
The FTO gene at Chromosome 16q12.2 has been identified in research as a direct modulator of circadian rhythm sensitivity, influencing the molecular mechanisms through which the circadian clock responds to light, meal timing, and temperature signals that set the biological day. FTO variants alter the sensitivity of these circadian entrainment mechanisms in ways that predispose carriers to delayed sleep phase, melatonin onset delay, and disrupted circadian alignment under the environmental conditions of modern Pakistani urban life. This genetic predisposition means that Pakistani patients with the FTO associated metabolic profile may experience more severe melatonin disruption from the same environmental exposures, and more profound metabolic consequences from that disruption, than patients without it. Dr. Zaar incorporates circadian rhythm assessment into the comprehensive evaluation of every Pakistani obesity patient, because the FTO associated circadian vulnerability makes melatonin disruption a metabolically significant finding in a substantial proportion of those evaluated.
Melatonin sensitises insulin receptors in peripheral tissues, particularly in skeletal muscle and adipose tissue, through its direct action on melatonin receptors expressed in these metabolically active tissues. When melatonin is disrupted, this insulin sensitising effect is removed overnight, allowing insulin resistance to deepen progressively across each disrupted night without the overnight receptor sensitisation that adequate melatonin provides. Simultaneously, the cortisol suppression that melatonin normally provides during the overnight period fails, allowing cortisol to drive hepatic glucose production through the night, demanding continuous insulin secretion, and progressively exhausting the pancreatic beta cell capacity that sustained overnight insulin demand depletes. Pakistani patients with melatonin disruption are experiencing insulin resistance that worsens every night as a direct consequence of the circadian hormonal failure, and this nightly insulin resistance deepening cannot be addressed by any dietary or pharmacological intervention that does not restore the melatonin rhythm driving it.
Evening carbohydrate craving in melatonin disrupted Pakistani patients is a biological signal rather than a psychological one, driven by the nocturnal glucose dysregulation and serotonin depletion that disrupted melatonin produces. Melatonin supports serotonin synthesis through its relationship with the tryptophan serotonin melatonin biosynthetic pathway, when melatonin is disrupted, serotonin availability falls in the evening hours, driving the carbohydrate seeking behaviour through which the brain attempts to raise serotonin through dietary tryptophan provision. Simultaneously, the insulin resistance and cortisol elevation of melatonin disruption produce evening blood glucose instability that drives carbohydrate craving through the reactive hypoglycaemia mechanism. The Pakistani patient who eats heavily in the evening is frequently responding to a biological signal from a disrupted circadian hormonal system, not expressing a lack of dietary discipline that no amount of advice or willpower can sustainably address.
The majority of daily growth hormone secretion occurs during the first slow wave sleep cycle of the night, the deep sleep stage that melatonin onset and depth of melatonin production facilitate. When melatonin is delayed in onset, reduced in amplitude, or disrupted in its circadian precision, the slow wave sleep it should facilitate is delayed, shortened, or eliminated, and growth hormone secretion, which is entirely dependent on slow wave sleep architecture, is correspondingly suppressed. Pakistani patients with melatonin disruption experience a nightly growth hormone deficit that accumulates across months and years, progressively shifting body composition toward fat and away from muscle, impairing cellular repair, and deepening the metabolic deterioration that inadequate growth hormone produces. The growth hormone deficiency of melatonin disruption is not a pituitary disorder, it is a circadian disorder, and it resolves when sleep architecture is restored rather than when growth hormone itself is treated.
Melatonin is a potent immunomodulatory hormone, it coordinates the overnight immune activity in which cytokine production, immune cell proliferation, and inflammatory regulation occur in their most efficient and most calibrated form. During normal melatonin driven deep sleep, the immune system conducts its most significant regulatory activity, clearing inflammatory debris, calibrating cytokine balance, and producing the anti-inflammatory signals that prevent chronic low grade inflammation from accumulating. When melatonin is disrupted and deep sleep is impaired, this overnight immune calibration fails, and the inflammatory cytokines that should have been regulated overnight persist into the following day, accumulating progressively and driving the chronic low grade inflammatory state that characterises Pakistani obesity. Pakistani patients with melatonin disruption carry an inflammatory burden that is in part circadian in origin, driven by the loss of the overnight anti-inflammatory regulatory function that adequate melatonin and deep sleep provide.
Melatonin disruption is fully correctable in the majority of Pakistani patients when its environmental, metabolic, and biological drivers are addressed systematically and simultaneously. Eliminating blue light screen exposure in the two hours before intended sleep time is the single most important environmental intervention, removing the primary suppressor of melatonin onset that Pakistani screen habits create nightly. Achieving complete bedroom darkness removes the ambient light exposure that suppresses melatonin synthesis through closed eyelids. Shifting the largest meal to earlier in the evening reduces the peripheral circadian clock conflict that disrupts melatonin timing. Precisely timed low dose melatonin, used as a circadian anchor rather than as a sedative, assists the endogenous rhythm reset during the initial correction period. Visceral fat reduction removes the inflammatory pineal suppression. And insulin resistance treatment reduces the nocturnal glucose and cortisol dysregulation that prevents deep sleep maintenance even when melatonin is present. THE CHROMOSOME protocol addresses all of these simultaneously, because circadian restoration, like every other aspect of metabolic health in Pakistani patients, is never the product of a single intervention.